This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Saskatchewan directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,239,300
Advancing CB1R Cannabinoid Receptor Positive Allosteric Modulators for Novel Therapies in Temporal Lobe Epilepsy
CIHR · 2026 · Principal investigator
- $692,325
Development of Novel Type 1 Cannabinoid Receptor Positive Allosteric Modulators for Infantile Spasms
CIHR · 2019 · Co-investigator
Advancing CB1R Cannabinoid Receptor Positive Allosteric Modulators for Novel Therapies in Temporal Lobe Epilepsy
Principal investigators: Laprairie, Robert B; Botterill, Justin J; Thakur, Ganesh A
Keywords: Allosteric Modulation; Cannabinoid; Drug Discovery; Epilepsy; Molecular Biology; Neuroscience; Pharmacology; Structure-Activity Relationships; Type 1 Cannabinoid Receptor
Development of Novel Type 1 Cannabinoid Receptor Positive Allosteric Modulators for Infantile Spasms
Principal investigators: Laprairie, Robert B
Keywords: Allosteric Modulation; Cannabinoid; Drug Discovery; Epilepsy; Molecular Biology; Neuroscience; Pharmacology; Structure-Activity Relationships; Type 1 Cannabinoid Receptor (Cb1r)
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.